文献速递中毒与环境急症

其他类治疗错误:某中毒中心报告的「其他」治疗错误特征分析

The others: characterizing "other" therapeutic errors reported to a poison center.
PubMed 文献 · Clin Toxicol (Phila) · 2019-01-02
一句话结论单中毒中心回顾性图表复习显示,编码为「其他错误剂量」或「其他/未知治疗错误」的病例中,多数可重新归类为现有预设场景,其中双倍剂量最常见(477/971),作者建议将双倍剂量和剂量规格错误新增为预设编码场景。

该研究对2000年1月1日至2017年9月30日期间某单中毒中心接诊或转诊至医院的、至少有一个场景编码为「其他错误剂量」(OI)或「其他/未知治疗错误」(OU)的治疗错误暴露进行了回顾性图表复习,共识别3413例。其中726例经评估并非治疗错误,重新编码为故意误用(430例)、药物不良反应(204例)或其他非治疗错误(82例);剩余病例中1726例被重新编码为16种现有治疗错误场景之一。重新编码后仍有971例编码为OI或OU,其中大多数为双倍、三倍、四倍或高于推荐剂量(477/971),另一常见错误为剂量规格错误(81/971);其余场景各不足50例且超过40种不同场景。作者认为,大多数OI或OU病例可重新编码为NPDS预设治疗错误场景或非错误暴露原因,考虑双倍剂量占比大及片剂剂量规格错误的独特性,建议将这些场景新增为预设编码场景,以利于未来研究和患者宣教。

要点

  • 共识别3413例至少一个场景编码为OI或OU的治疗错误暴露,经复习后726例被评估为非治疗错误,重新编码为故意误用430例、药物不良反应204例、其他非治疗错误82例。
  • 剩余病例中1726例可重新编码为16种现有治疗错误场景之一;重新编码后仍有971例维持OI或OU编码。
  • 971例维持OI或OU编码的病例中,477例为双倍、三倍、四倍或高于推荐剂量,81例为剂量规格错误,其余各场景均不足50例且超过40种不同场景。
  • 作者认为大多数OI或OU病例可重新编码为NPDS预设治疗错误场景或非错误暴露原因,并建议将双倍剂量和剂量规格错误新增为预设编码场景,以利于未来研究和患者宣教。

适用人群与场景

  • 2000年1月1日至2017年9月30日期间,某单中毒中心接诊或转诊至医院的、至少一个场景编码为「其他错误剂量」(OI)或「其他/未知治疗错误」(OU)的治疗错误暴露病例。

研究设计与关键结果

  • 研究类型:回顾性、单中毒中心图表复习;共识别3413例至少一个场景编码为OI或OU的治疗错误暴露病例。
  • 726例经评估并非治疗错误,重新编码为故意误用(430例)、药物不良反应(204例)或其他非治疗错误(82例)。
  • 剩余病例中1726例被重新编码为16种现有治疗错误场景之一;重新编码后仍有971例编码为OI或OU。
  • 971例维持OI或OU编码的病例中,477例为双倍、三倍、四倍或高于推荐剂量,81例为剂量规格错误;其余场景各不足50例且超过40种不同场景。

证据类型、等级与局限

  • 证据类型:回顾性、单中毒中心图表复习。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,大多数编码为OI或OU的病例可重新编码为NPDS预设治疗错误场景或非错误暴露原因。
  • 作者认为,考虑双倍剂量病例占比大及片剂剂量规格错误的独特性,可将这些场景新增为预设编码场景,以利于未来研究和患者宣教。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Therapeutic errors are costly and result in unplanned hospital visits. Recent poison center studies on therapeutic errors have focused on coded data from either the National Poison Data System (NPDS) or individual poison centers. Approximately 21% of therapeutic errors reported to NPDS are coded as "other incorrect dose" (OI) or "other/unknown therapeutic error" (OU). The purpose of this study was to characterize errors coded as OI or OU reported to a single poison center. Methods: Retrospective, single poison center chart review was conducted of therapeutic error exposures with at least one scenario coded as OI or OU seen in or referred to hospitals from 1/1/2000 to 9/30/2017. Cases were reviewed and re-coded to predefined or newly created scenarios. Results: A total of 3413 cases were identified. There were 726 cases assessed as not therapeutic errors and re-coded as either intentional misuse (430), adverse reaction drug (204), or other non-therapeutic errors (82). Of the remaining cases, 1726 cases were re-coded to one of the 16 existing therapeutic error scenarios. After re-coding, there remained 971 coded as OI or OU. Most were due to double, triple, quadruple, or higher than recommended dose (477/971); an additional common error was mistaken strength (81/971). The remaining scenarios occurred in fewer than 50 cases each with greater than 40 different scenarios such that additional coded scenarios would not be feasible. Conclusions: Most cases coded as OI or OU could be recoded as one of the NPDS predefined therapeutic error scenarios or non-error reasons for exposure. Considering the large proportion of double dose cases and the unique errors associated with mistaken strengths of tablets, these scenarios could be appropriate to add as new predefined coding scenarios, which would aid in future research and patient counseling.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Leonard JB, Klein-Schwartz W. The others: characterizing "other" therapeutic errors reported to a poison center. Clin Toxicol (Phila). 2019. PMID: 30600728. doi:10.1080/15563650.2018.1538520

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。